Open access · OA
via Europe PMC
Genetic Risk Architecture of Late-Onset Alzheimer's Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways.
Matei C, Palade NA, Dobri-Nicoara AM, Dumitriu DO, Mutu C, Popescu ASC, Pintea AL, Atasie D.
Life (Basel, Switzerland) · 2026
Abstract
Late-onset Alzheimer's disease (LOAD) is increasingly recognized as a complex, multifactorial disorder driven by the convergence of genetic susceptibility and interconnected molecular pathways, rather than a single linear pathogenic cascade. In this review, we integrate evidence from genome-wide association studies, sequencing analyses, and experimental research to map disease-associated single-nucleotide polymorphisms (SNPs) onto key biological processes underlying LOAD pathogenesis. Converging data consistently implicate a limited number of core domains, including amyloid-β metabolism, tau pathology, neuroinflammation, lipid homeostasis, endosomal-lysosomal trafficking, mitochondrial dysfunction(definition), and synaptic impairment. Importantly, genetic risk variants are not randomly distributed, but cluster within these pathways, exerting coordinated effects across multiple biological systems and supporting a network-based organization of disease. We further examine how these pathways interact at a systems level, highlighting key interfaces such as the amyloid-tau, lipid-immune, inflammation-proteostasis(definition), and mitochondria-synaptic dysfunction axes. These interconnected processes form self-reinforcing feedback loops that amplify neurodegeneration and contribute to disease progression. From a translational perspective, this integrated framework provides a mechanistic basis for the limited efficacy of single-target therapies and supports the development of multi-target and pathway-oriented strategies, as well as precision medicine approaches based on genetic and biomarker integration. Collectively, this review supports a unified model of LOAD as a polygenic network disorder and underscores the importance of pathway convergence in understanding disease heterogeneity and guiding future therapeutic development.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/life16101749
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
C, M., NA, P., AM, D., DO, D., C, M., ASC, P., AL, P., & D., A. (2026). Genetic Risk Architecture of Late-Onset Alzheimer's Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways. <em>Life (Basel, Switzerland)</em>. https://doi.org/10.3390/life16101749
Vancouver
C M, NA P, AM D, DO D, C M, ASC P, et al. Genetic Risk Architecture of Late-Onset Alzheimer's Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways. Life (Basel, Switzerland). 2026. doi:10.3390/life16101749.
BibTeX
@article{matei2026Geneti,
title = {Genetic Risk Architecture of Late-Onset Alzheimer's Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways.},
author = {Matei C and Palade NA and Dobri-Nicoara AM and Dumitriu DO and Mutu C and Popescu ASC and Pintea AL and Atasie D.},
journal = {Life (Basel, Switzerland)},
year = {2026},
doi = {10.3390/life16101749},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2026
Open access · OA
Polypharmacology of Pathway Crosstalk in Neurodegenerative Diseases: Chemical Modulation of Interconnected Signaling Networks.
Frontiers in aging 2026
Open access · OA
Investigating the research trajectory and future trends in type 2 diabetes mellitus and aging: a bibliometric analysis from 2009 to 2025 based on big data.
Frontiers in Synaptic Neuroscience 2026
Open access · CC-BY
Aging and Alzheimer’s: the critical role of mitochondrial dysfunction and synaptic alterations
Journal of Food and Drug Analysis 2025
Open access · CC-BY
The rhythm of decline: Circadian disruption in neurodegeneration
Lung 2026
Open access · OA
MUC5B/TGF-β/KL-6 Signaling in Idiopathic Pulmonary Fibrosis: Genetic Susceptibility to Profibrotic Progression and Clinical Perspectives.
Molecular biology reports 2026
Citation only